Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
KNSA compared with HRTX: revenue, margins and what each company keeps, and the suppliers and customers both name
KNSA
Kiniksa Pharmaceuticals International, plc
Change
Mkt cap
Revenue
Revenue
HRTX
Heron Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
KNSA
Kiniksa Pharmaceuticals International, plc
vs
HRTX
Heron Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
HRTX: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only KNSA
10
REGN
Regeneron
supplier
BIIB
Biogen MA
supplier
—
Samsung
unlisted
supplier
—
Beth Israel Deaconess Medical Center, Inc. ("BIDMC")
unlisted
supplier
6 more · KNSA chain
›
Shared
0
No disclosed counterparties: HRTX.
Only HRTX
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
KNSA, solid
HRTX, dashed
KNSA
Kiniksa Pharmaceuticals International, plc
Change
92.17
▼
−5.53%
· post 92.18
Mkt cap
$7.2B
Revenue
$286M
Q3 FY26
Revenue
$678M
FY25
HRTX
Heron Therapeutics, Inc.
Change
0.28
▼
−4.38%
· post 0.28
Closed
Oct 30 '26
Mkt cap
$52.7M
Revenue
$38M
Q2 FY26
Revenue
$155M
FY25
vs
Compare
Closed
Oct 30 '26
KNSA
Kiniksa Pharmaceuticals International, plc
vs
HRTX
Heron Therapeutics, Inc.
92.17
▼
−5.53%
post 92.18
Price
0.28
▼
−4.38%
post 0.28
$7.2B
Mkt cap
$52.7M
Q3 FY26
$286M
Revenue
$38M
Q2 FY26
FY25
$678M
Revenue
$155M
FY25
Change
Change
KNSA
92.17
▼
−5.53%
vs
HRTX
0.28
▼
−4.38%
Closed
Oct 30 '26